Damiano Fortuna is a seasoned executive and entrepreneur in the medical technology field, with over 25 years of experience spanning R&D, operations, and international business development. He co-founded Epica International Inc., where he served as President and Director until 2022. Previously, he was CEO and Chairman of Imaginalis S.r.l., which is a leading 3D CBCT manufacturer with 45 employees and 46 patents. His earlier career includes leading the Photobiolab Research Unit at El.En. S.p.A. and serving as a Medical Veterinary Officer in the Italian Army.

Head of Project Management Office at Toscana Life Sciences, the main regional player in the biomedical field and policy support for Tuscany Regional Government. He obtained his degree cum laude in International Relations at Federico II University in Napoli, with a major in international economics. He is also Executive MBA laureate at Bologna Business School (University of Bologna). He obtained his Post Graduate master’s degree in Project Management in Rome and a certification in Intellectual Property Management at University of Bonn (DE). He is currently a PhD student at IMT School of advanced studies in Lucca – Management of digital transformation | Precision Medicine. He is coordinator/partner of the following European projects: European Partnership for Personalised Medicine, Region4PerMed, Sino-EuPerMed, BornToGetThere, EraPerMed, ICPerMed; Transcan3, AI4Diag, MammoScreen; EP PerMed.

He is currently working as a Sales Manager at Erre Quadro. With a degree in Mechanical Engineering, he led Erre Quadro’s patent analysis team until the end of 2022. An expert in competitive and patent evaluation analysis to support innovation processes for large industrial groups and SMEs, he specializes in multi-parametric patent analyses, including mapping, technology monitoring, state-of-the-art studies, and technology foresight. He has taken part in several Erasmus+ innovation projects as an expert in quantitative methodologies for technology foresight.